1. 617. Pharmacodynamics of Ceftolozane-Tazobactam (C/T) as Monotherapy and in Combination with Tobramycin or Fosfomycin Against P.aeruginosa with C/T MICs at or Above 4mg/L. (15th December 2022) Authors: MacGowan, Alasdair P; Attwood, Marie; Griffin, Pippa; Noel, Alan Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection. (17th July 2018) Authors: Noel, Alan R; Bowker, Karen E; Attwood, Marie; MacGowan, Alasdair P Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 9(2018) Page Start: 2411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications. Issue 2 (2nd April 2021) Authors: Mankelow, Tosti J.; Singleton, Belinda K.; Moura, Pedro L.; Stevens‐Hernandez, Christian J.; Cogan, Nicola M.; Gyorffy, Gyongyver; Kupzig, Sabine; Nichols, Luned; Asby, Claire; Pooley, Jennifer; Ruffino, Gabriella; Hosseini, Faroakh; Moghaddas, Fiona; Attwood, Marie; Noel, Alan; Cooper, Alex; Arn... Journal: EJHaem Issue: Volume 2:Issue 2(2021) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cefepime pharmacodynamic targets against Enterobacterales employing neutropenic murine lung infection and in vitro pharmacokinetic models. (18th October 2022) Authors: Muller, Anouk E; Attwood, Marie; Van den berg, Sanne; Chavan, Rajesh; Periasamy, Hariharan; Noel, Alan; MacGowan, Alasdair Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 12(2022) Page Start: 3504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections. (17th May 2020) Authors: MacGowan, Alasdair; Attwood, Marie; Bowker, Karen; Noel, Alan Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 9(2020) Page Start: 2711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. (8th February 2022) Authors: Noel, Alan R; Attwood, Marie; Bowker, Karen E; MacGowan, Alasdair P; Albur, Maha Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 5(2022) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2. (March 2021) Authors: MacGowan, Alasdair; Hamilton, Fergus; Bayliss, Mark; Read, Liam; Attwood, Marie; Noel, Alan; Grier, Sally; Morley, Anna; Arnold, David; Maskell, Nicholas Journal: Journal of global antimicrobial resistance Issue: Volume 24(2021) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay. Issue 6 (December 2020) Authors: Hamilton, Fergus; Muir, Peter; Attwood, Marie; Vipond, Alan Noela Barry; Hopes, Richard; Moran, Ed; Maskell, Nick; Warwick, Deborah; Albur, Mahableshwar; Turner, Jonathan; MacGowan, Alasdair; Arnold, David Journal: Journal of infection Issue: Volume 81:Issue 6(2020) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗